World

Belgian airspace reopens after short closure over technical issue

Jan 31, 2025

Brussels [Belgium], January 31: Belgian airspace reopened on Thursday after a closure lasting a little over an hour due to a technical issue with air traffic controllers' Skeyes computer system, Brussels airport said on social media platform X.
The disruption ended after Skeyes rebooted its system, a Sketes spokesperson told local media.
The closure forced a flight carrying Slovak Prime Minister Robert Fico to a meeting with European Commission officials in Brussels to turn around and return to Slovakia, a spokesperson for the country's EU representative office said.
A Skeyes spokesperson told local news broadcaster VRT that it became clear at about 3 p.m. (1400 GMT) that the air traffic control system used to manage Belgian airspace was "not functioning properly".
He added that all aircraft operating within the airspace controlled by Skeyes at that time - up to an altitude of approximately 7,500 metres (24,600 feet) - were rerouted to neighbouring countries using a backup system.
Belgium's main airports are in Brussels (Zaventem) and Charleroi, with smaller airports in Antwerp, Liege and Ostend.
Source: Fijian Broadcasting Corporation

More news

Sirolimus-Coated Balloon Matches Drug-Eluting Stent at One Year in Large International TRANSFORM II Trial

Tampa (Florida) [US], November 2: Sirolimus-coated balloon (SCB) strategy was non-inferior to contemporary everolimus-eluting stents (EES) for Target Lesion Failure (TLF) at 12 months in patients with de novo coronary artery disease. These are the results of the TRANSFORM II randomised trial, presented today as a Late-Breaking Clinical Trial at TCT 2026 and accepted in The Lancet which confirm how MagicTouch Sirolimus Coated Balloon (Concept Medical) matches contemporary best in class stent. Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting in de novo coronary artery disease.

Nov 02, 2026